These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 31696985)

  • 1. Conventional plasmid DNAs with a CpG-containing backbone achieve durable transgene expression in mouse liver.
    Suzuki T; Wakao Y; Goda T; Kamiya H
    J Gene Med; 2020 Jan; 22(1):e3138. PubMed ID: 31696985
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Durable Transgene Expression Driven by CpG-Free and -Containing Promoters in Plasmid DNA with CpG-Free Backbone.
    Suzuki T; Goda T; Kamiya H
    Biol Pharm Bull; 2018; 41(9):1489-1493. PubMed ID: 30175785
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sustained, high transgene expression in liver with plasmid vectors using optimized promoter-enhancer combinations.
    Magnusson T; Haase R; Schleef M; Wagner E; Ogris M
    J Gene Med; 2011 Jul; 13(7-8):382-91. PubMed ID: 21721074
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High and sustained transgene expression in vivo from plasmid vectors containing a hybrid ubiquitin promoter.
    Yew NS; Przybylska M; Ziegler RJ; Liu D; Cheng SH
    Mol Ther; 2001 Jul; 4(1):75-82. PubMed ID: 11472109
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CpG-free plasmid expression cassettes for cystic fibrosis gene therapy.
    Pringle IA; Hyde SC; Connolly MM; Lawton AE; Xu B; Nunez-Alonso G; Davies LA; Sumner-Jones SG; Gill DR
    Biomaterials; 2012 Oct; 33(28):6833-42. PubMed ID: 22727465
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term transgene expression from plasmid DNA gene therapy vectors is negatively affected by CpG dinucleotides.
    Hodges BL; Taylor KM; Joseph MF; Bourgeois SA; Scheule RK
    Mol Ther; 2004 Aug; 10(2):269-78. PubMed ID: 15294174
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased persistence of lung gene expression using plasmids containing the ubiquitin C or elongation factor 1alpha promoter.
    Gill DR; Smyth SE; Goddard CA; Pringle IA; Higgins CF; Colledge WH; Hyde SC
    Gene Ther; 2001 Oct; 8(20):1539-46. PubMed ID: 11704814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anatomy of plasmid DNAs with anti-silencing elements.
    Kanda GN; Miyamoto S; Kobayashi M; Matsuoka I; Harashima H; Kamiya H
    Int J Pharm; 2014 Apr; 464(1-2):27-33. PubMed ID: 24472643
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interplay of Promoter Usage and Intragenic CpG Content: Impact on GFP Reporter Gene Expression.
    Krinner S; Heitzer A; Asbach B; Wagner R
    Hum Gene Ther; 2015 Dec; 26(12):826-40. PubMed ID: 26414116
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased duration of transgene expression in the lung with plasmid DNA vectors harboring adenovirus E4 open reading frame 3.
    Yew NS; Marshall J; Przybylska M; Wysokenski DM; Ziegler RJ; Rafter PW; Li C; Armentano D; Cheng SH
    Hum Gene Ther; 1999 Jul; 10(11):1833-43. PubMed ID: 10446923
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimization of transcriptional regulatory elements for constructing plasmid vectors.
    Xu ZL; Mizuguchi H; Ishii-Watabe A; Uchida E; Mayumi T; Hayakawa T
    Gene; 2001 Jul; 272(1-2):149-56. PubMed ID: 11470520
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transgene sequences free of CG dinucleotides lead to high level, long-term expression in the lung independent of plasmid backbone design.
    Bazzani RP; Pringle IA; Connolly MM; Davies LA; Sumner-Jones SG; Schleef M; Hyde SC; Gill DR
    Biomaterials; 2016 Jul; 93():20-26. PubMed ID: 27061267
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The EF-1α promoter maintains high-level transgene expression from episomal vectors in transfected CHO-K1 cells.
    Wang X; Xu Z; Tian Z; Zhang X; Xu D; Li Q; Zhang J; Wang T
    J Cell Mol Med; 2017 Nov; 21(11):3044-3054. PubMed ID: 28557288
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Minimal size MIDGE vectors improve transgene expression in vivo.
    Schakowski F; Gorschlüter M; Buttgereit P; Märten A; Lilienfeld-Toal MV; Junghans C; Schroff M; König-Merediz SA; Ziske C; Strehl J; Sauerbruch T; Wittig B; Schmidt-Wolf IG
    In Vivo; 2007; 21(1):17-23. PubMed ID: 17354609
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Persistence of plasmid-mediated expression of transgenes in human mesenchymal stem cells depends primarily on CpG levels of both vector and transgene.
    Bruter AV; Kandarakov OF; Belyavsky AV
    J Gene Med; 2018 Feb; 20(2-3):e3009. PubMed ID: 29424052
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation between transgen expression and plasmid DNA loss in mouse liver.
    Togashi R; Harashima H; Kamiya H
    J Gene Med; 2013; 15(6-7):242-8. PubMed ID: 23765503
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low generation PAMAM dendrimer and CpG free plasmids allow targeted and extended transgene expression in tumors after systemic delivery.
    Navarro G; Maiwald G; Haase R; Rogach AL; Wagner E; de Ilarduya CT; Ogris M
    J Control Release; 2010 Aug; 146(1):99-105. PubMed ID: 20438778
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myocardial injection of CA promoter-based plasmid mediates efficient transgene expression in rat heart.
    Huang J; Ito Y; Kobune M; Sasaki K; Nakamura K; Dehari H; Takahashi K; Ikeda K; Uchida H; Kato K; Hamada H
    J Gene Med; 2003 Oct; 5(10):900-908. PubMed ID: 14533199
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CpG methylation of a plasmid vector results in extended transgene product expression by circumventing induction of immune responses.
    Reyes-Sandoval A; Ertl HC
    Mol Ther; 2004 Feb; 9(2):249-61. PubMed ID: 14759809
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficient in vivo transfection and safety profile of a CpG-free and codon optimized luciferase plasmid using a cationic lipophosphoramidate in a multiple intravenous administration procedure.
    Lindberg MF; Le Gall T; Carmoy N; Berchel M; Hyde SC; Gill DR; Jaffrès PA; Lehn P; Montier T
    Biomaterials; 2015 Aug; 59():1-11. PubMed ID: 25941996
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.